{
    "nctId": "NCT00034827",
    "briefTitle": "A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer",
    "officialTitle": "A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung Cancer, Breast Cancer, Colon Cancer, or Pancreatic Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Colorectal Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 172,
    "primaryOutcomeMeasure": "Overall objective response and clinical benefit response",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients who are at least 18 years or older who have pathological or hiostological confirmation of colorectal, nonsmall cell lung cancer, breast, or pancreas cancer.\n* No more than 1 prior chemo for lung or colon cancer, no more than 2 for breast no prior chemotherapy for pancreas cancer.\n* Original or recent tumor tissue must be available.\n* Patients must have been off prior chemoptherapy for 4 weeks and radiation for 3 weeks.\n* Patients must have adequate renal, liver, and bone marrow function, not have serious infection or life-threatening illness (unrelated to tumor).\n* Must be able to swallow capsules and not have gastrointestinal disorders that may affect absorption of the drug.\n\nExclusion Criteria:\n\n* Unstable medical condition\n* prior chemotherapy within 4 week of screening\n* series infection\n* other tumor types\n* ECOG performance status of 3 or 4.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}